Cite
HARVARD Citation
Ye, L. et al. (2019). Epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer. EMBO molecular medicine. 11 (12), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ye, L. et al. (2019). Epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer. EMBO molecular medicine. 11 (12), p. n/a. [Online].